Affymetrix Stock Slides on News of Defective Mouse Arrays: Analysts Not Worried

Mar 07, 2001

NEW YORK, March 7 – After Affymetrix disclosed that its U74 Mouse arrays contained defective sequences, the microarray maker’s shares slid nearly 11 percent Wednesday by midday.

The company’s shares were down $5 15/16, at 50 1/16 in early-afternoon trading on the Nasdaq.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Privacy Policy Information, Please

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

Moving the Parts About

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

This Week in Science

In Science this week: genetic overlap among many psychiatric disorders, and more.

Just Skip that Step

The Economist writes that an increasing number of scientific journals don't do peer review.

Main menu